‘Covid Ebbing As R-Value Drops To Below 1’

New Delhi : After breaching the value of 1 in the first week of August, the R number, which reflects how rapidly the coronavirus pandemic is spreading, has been steadily ebbing, according to researchers at the Institute of Mathematical Sciences, Chennai.

“India’s R has fallen to around 0.9,” Sitbara Sinha, who is leading the research, said, citing their data.

If R is lesser than 1, it means the number of newly infected people is lower than the number of infected people in the preceding period and the disease incidence is going down.

The R-value of Kerala, which has the highest number of active cases in the country, is now below 1 after a gap of seven months, signalling a relief to authorities who have been struggling to bring down the injection levels in the state.

The northeastern states seem to have finally come out of the second wave, Sinha said.

The R-value between August 14-16, calculated by the researchers now stands at 0.89.

The R-value for Maharashtra, another state which has a high number of cases, is 0.89, the data shows.

However, Himachal Pradesh continues to have an R value of above 1, although it reduced in the last few days, while Tamil Nadu and Uttarakhand still have R very close to 1, Sinha said.

Among the major cities, the R-value of Mumbai was lowest (0.70 from August 10-13), followed by Delhi (0.85 from July 31 to August 4), Bengaluru (0.94 from August 15-17), Chennai (0.97 from August 15-17). However, the R value remains high for Kolkata (1.08 from August 11-15), Pune (1.05 from August 10-14).

The Reproduction number or R refers to how many people an infected person infects, on average. In other words, it tells how ‘efficiently’ a virus is spreading.

A smaller R indicates the disease is on a decline. Conversely, if R is greater than 1, the number of infected people is increasing in each round – technically, this is what is called the epidemic phase.

After the devastating second wave that saw hospitals and health infrastructure being overwhelmed by the patients infected by SARS-CoV2 coronavirus, the R-value started to decline.

During the March-May period, thousands of people died due to the infection while lakhs were infected.

In its bulletin on Wednesday, the Ministry of Health said India saw a single-day rise of 25,166 new COVID-19 cases, the lowest in 154 days, taking the tally to 3,22,50,679.

  • Related Posts

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre